George Eric Davis insider trades: Biomarin Pharmaceutical (BMRN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
76 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | BMRN | ↓ Sell | 17,557 | $66.28 | $1.2M | Direct | Sep 3, 2026 (1d) |
| May 28, 2024 | BMRN | ↓ Sell | 40,850 | $74.51 | $3.0M | Direct | May 30, 2024 (2d) |
| May 2, 2024 | BMRN | ↓ Sell | 1,850 | $85.01 | $157K | Direct | May 6, 2024 (4d) |
| Mar 28, 2024 | BMRN | ↓ Sell | 24,602 | $88.34 | $2.2M | Direct | Apr 1, 2024 (4d) |
| Dec 13, 2023 | BMRN | ↓ Sell | 13,764 | $95.30 | $1.3M | Direct | Dec 14, 2023 (1d) |
| Aug 8, 2023 | BMRN | ↓ Sell | 11,000 | $89.42 | $984K | Direct | Aug 9, 2023 (1d) |
| Aug 9, 2022 | BMRN | ↓ Sell | 51,216 | $95.96 | $4.9M | Direct | Aug 11, 2022 (2d) |
| Jul 8, 2022 | BMRN | ↓ Sell | 7,398 | $90.00 | $666K | Direct | Jul 11, 2022 (3d) |
| May 2, 2022 | BMRN | ↓ Sell | 15,347 | $80.38 | $1.2M | Direct | May 4, 2022 (2d) |
| Mar 21, 2022 | BMRN | ↓ Sell | 6,129 | $81.29 | $498K | Direct | Mar 23, 2022 (2d) |
| Aug 2, 2021 | BMRN | ↓ Sell | 5,518 | $76.69 | $423K | Direct | Aug 4, 2021 (2d) |
| May 3, 2021 | BMRN | ↓ Sell | 4,673 | $78.30 | $366K | Direct | May 4, 2021 (1d) |
| Apr 19, 2021 | BMRN | ↓ Sell | 2,709 | $79.58 | $216K | Direct | Apr 20, 2021 (1d) |
| May 1, 2020 | BMRN | ↓ Sell | 12,504 | $89.38 | $1.1M | Direct | May 4, 2020 (3d) |
| Nov 26, 2019 | BMRN | ↓ Sell | 3,190 | $79.66 | $254K | Direct | Nov 27, 2019 (1d) |
| Mar 25, 2019 | BMRN | ↓ Sell | 3,363 | $87.86 | $295K | Direct | Mar 26, 2019 (1d) |
| Mar 19, 2019 | BMRN | ↓ Sell | 7,907 | $93.92 | $743K | Direct | Mar 21, 2019 (2d) |
| Sep 14, 2018 | BMRN | ↓ Sell | 2,216 | $99.45 | $220K | Direct | Sep 18, 2018 (4d) |
| Sep 13, 2018 | BMRN | ↓ Sell | 12,000 | $99.57 | $1.2M | Direct | Sep 17, 2018 (4d) |
| Mar 23, 2018 | BMRN | ↓ Sell | 3,350 | $81.35 | $273K | Direct | Mar 27, 2018 (4d) |
| Mar 16, 2018 | BMRN | ↓ Sell | 3,818 | $83.88 | $320K | Direct | Mar 20, 2018 (4d) |
| Mar 5, 2018 | BMRN | ↓ Sell | 2,105 | $79.04 | $166K | Direct | Mar 7, 2018 (2d) |
| Feb 1, 2018 | BMRN | ↓ Sell | 30,000 | $90.66 | $2.7M | Direct | Feb 5, 2018 (4d) |
| Nov 30, 2017 | BMRN | ↓ Sell | 1,200 | $85.64 | $103K | Direct | Dec 4, 2017 (4d) |
| Jun 23, 2017 | BMRN | ↓ Sell | 9,844 | $96.60 | $951K | Direct | Jun 27, 2017 (4d) |
| Jun 5, 2017 | BMRN | ↓ Sell | 9,471 | $91.04 | $862K | Direct | Jun 7, 2017 (2d) |
| May 5, 2017 | BMRN | ↓ Sell | 2,500 | $100.34 | $251K | Direct | May 9, 2017 (4d) |
| Mar 16, 2017 | BMRN | ↓ Sell | 2,238 | $91.96 | $206K | Direct | Mar 17, 2017 (1d) |
| Mar 6, 2017 | BMRN | ↓ Sell | 1,498 | $93.32 | $140K | Direct | Mar 8, 2017 (2d) |
| Nov 18, 2016 | BMRN | ↓ Sell | 5,000 | $90.42 | $452K | Direct | Nov 22, 2016 (4d) |
| Aug 1, 2016 | BMRN | ↓ Sell | 2,167 | $100.00 | $217K | Direct | Aug 3, 2016 (2d) |
| Jul 7, 2016 | BMRN | ↓ Sell | 2,167 | $90.00 | $195K | Direct | Jul 11, 2016 (4d) |
| May 10, 2016 | BMRN | ↓ Sell | 14,658 | $85.11 | $1.2M | Direct | May 10, 2016 (0d) |
| Mar 14, 2016 | BMRN | ↓ Sell | 1,996 | $86.21 | $172K | Direct | Mar 16, 2016 (2d) |
| Dec 16, 2015 | BMRN | ↓ Sell | 1,362 | $100.00 | $136K | Direct | Dec 17, 2015 (1d) |
| May 18, 2015 | BMRN | ↓ Sell | 2,558 | $125.26 | $320K | Direct | May 19, 2015 (1d) |
| Mar 13, 2015 | BMRN | ↓ Sell | 15,000 | $120.87 | $1.8M | Direct | Mar 17, 2015 (4d) |
| Mar 2, 2015 | BMRN | ↓ Sell | 23,000 | $108.31 | $2.5M | Direct | Mar 4, 2015 (2d) |
| Nov 25, 2014 | BMRN | ↓ Sell | 20,000 | $89.75 | $1.8M | Direct | Nov 28, 2014 (3d) |
| Oct 30, 2014 | BMRN | ↓ Sell | 15,000 | $83.20 | $1.2M | Direct | Nov 3, 2014 (4d) |
| Sep 19, 2014 | BMRN | ↓ Sell | 17,536 | $69.75 | $1.2M | Direct | Sep 23, 2014 (4d) |
| Feb 20, 2014 | BMRN | ↓ Sell | 20,000 | $80.00 | $1.6M | Direct | Feb 24, 2014 (4d) |
| May 14, 2013 | BMRN | ↓ Sell | 20,000 | $70.34 | $1.4M | Direct | May 15, 2013 (1d) |
| May 13, 2013 | BMRN | ↓ Sell | 2,590 | $69.29 | $179K | Direct | May 14, 2013 (1d) |
| May 3, 2013 | BMRN | ↓ Sell | 5,854 | $67.19 | $393K | Direct | May 7, 2013 (4d) |
| Mar 4, 2013 | BMRN | ↓ Sell | 4,000 | $60.18 | $241K | Direct | Mar 6, 2013 (2d) |
| Feb 27, 2013 | BMRN | ↓ Sell | 8,000 | $56.90 | $455K | Direct | Feb 28, 2013 (1d) |
| Nov 19, 2012 | BMRN | ↓ Sell | 7,363 | $48.50 | $357K | Direct | Nov 19, 2012 (0d) |
| Nov 12, 2012 | BMRN | ↓ Sell | 99,075 | $48.45 | $4.8M | Direct | Nov 14, 2012 (2d) |
| May 11, 2012 | BMRN | ↓ Sell | 42,309 | $37.91 | $1.6M | Direct | May 15, 2012 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BMRN insiders
Open-market trades in the last 12 months
About George Eric Davis's insider trades
George Eric Davis is EVP, Chief Legal Officer at Biomarin Pharmaceutical (BMRN). Since Feb 22, 2007, George has reported 3 open-market purchases worth $35K and 73 sales worth $53.4M on SEC Form 4. In the last 12 months: 1 sale ($1.2M).
Their filings also include grants and awards (52 filings), option exercises (50 filings), shares withheld for taxes (35 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMRN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.